These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34039905)

  • 1. Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis.
    Gracies JM; Francisco GE; Jech R; Khatkova S; Rios CD; Maisonobe P;
    J Neurol Phys Ther; 2021 Jul; 45(3):203-213. PubMed ID: 34039905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite active range of motion (CX
    Bayle N; Maisonobe P; Raymond R; Balcaitiene J; Gracies JM
    Clin Rehabil; 2020 Jun; 34(6):803-811. PubMed ID: 32336148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.
    Gracies JM; Esquenazi A; Brashear A; Banach M; Kocer S; Jech R; Khatkova S; Benetin J; Vecchio M; McAllister P; Ilkowski J; Ochudlo S; Catus F; Grandoulier AS; Vilain C; Picaut P;
    Neurology; 2017 Nov; 89(22):2245-2253. PubMed ID: 29093068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial.
    Esquenazi A; Stoquart G; Hedera P; Jacinto LJ; Dimanico U; Constant-Boyer F; Brashear A; Grandoulier AS; Vilain C; Picaut P; Gracies JM
    PM R; 2020 Sep; 12(9):853-860. PubMed ID: 32108436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis.
    McAllister PJ; Khatkova SE; Faux SG; Picaut P; Raymond R; Gracies JM
    J Rehabil Med; 2019 Oct; 51(10):813-816. PubMed ID: 31529136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
    Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
    PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
    Gracies JM; Jech R; Valkovic P; Marque P; Vecchio M; Denes Z; Vilain C; Delafont B; Picaut P
    Brain Commun; 2021; 3(1):fcaa201. PubMed ID: 33543139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on Passive Range of Motion and Functional Correlates After a Long-Term Lower Limb Self-Stretch Program in Patients With Chronic Spastic Paresis.
    Pradines M; Baude M; Marciniak C; Francisco G; Gracies JM; Hutin E; Bayle N
    PM R; 2018 Oct; 10(10):1020-1031. PubMed ID: 29505896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury.
    Esquenazi A; Brashear A; Deltombe T; Rudzinska-Bar M; Krawczyk M; Skoromets A; O'Dell MW; Grandoulier AS; Vilain C; Picaut P; Gracies JM
    PM R; 2021 May; 13(5):488-495. PubMed ID: 32741133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
    Gracies JM; O'Dell M; Vecchio M; Hedera P; Kocer S; Rudzinska-Bar M; Rubin B; Timerbaeva SL; Lusakowska A; Boyer FC; Grandoulier AS; Vilain C; Picaut P;
    Muscle Nerve; 2018 Feb; 57(2):245-254. PubMed ID: 28590525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S; Alila S; Elleuch W; Ayed HB; Mhiri C; Elleuch MH
    Pan Afr Med J; 2020; 35():55. PubMed ID: 32523646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study.
    O'Dell MW; Brashear A; Jech R; Lejeune T; Marque P; Bensmail D; Ayyoub Z; Simpson DM; Volteau M; Vilain C; Picaut P; Gracies JM
    PM R; 2018 Jan; 10(1):1-10. PubMed ID: 28634000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.
    Delgado MR; Tilton A; Carranza-Del Río J; Dursun N; Bonikowski M; Aydin R; Maciag-Tymecka I; Oleszek J; Dabrowski E; Grandoulier AS; Picaut P;
    Dev Med Child Neurol; 2021 May; 63(5):592-600. PubMed ID: 33206382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world effectiveness of abobotulinumtoxinA (Dysport®) in adults with upper limb spasticity in routine clinical practice: an observational study.
    Sarzyńska-Długosz I; Szczepańska-Szerej A; Drużdż A; Łukomski T; Ochudło S; Fabian A; Sobolewski P; Mariańska K; Maciejewska J; Mulek E; Niedzielska A; Raymond R; Brzózka MM; Jessa-Jabłońska M
    Neurol Neurochir Pol; 2020; 54(1):90-99. PubMed ID: 31956971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial.
    Hokazono A; Etoh S; Jonoshita Y; Kawahira K; Shimodozono M
    J Hand Ther; 2022; 35(4):507-515. PubMed ID: 33820711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
    Khan P; Riberto M; Frances JA; Chueire R; Amorim ACFG; Xerez D; Chung TM; Mercuri LHC; Longo AL; Lianza S; Maisonobe P; Ruiz-Schutz VC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33291807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided Self-rehabilitation Contract vs conventional therapy in chronic stroke-induced hemiparesis: NEURORESTORE, a multicenter randomized controlled trial.
    Gracies JM; Pradines M; Ghédira M; Loche CM; Mardale V; Hennegrave C; Gault-Colas C; Audureau E; Hutin E; Baude M; Bayle N;
    BMC Neurol; 2019 Mar; 19(1):39. PubMed ID: 30871480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.